#161: Single-drug polypharmacy; dabigatran use climbing in US; consistent benefit of apixaban: ARISTOTLE; sulfonylurea cardiotoxicity probed; Bonhoeffer to be struck off medical register

Single-drug polypharmacy; dabigatran use climbing in US; consistent benefit of apixaban: ARISTOTLE; sulfonylurea cardiotoxicity probed; Bonhoeffer to be struck off medical register

Source: Radio TheHeart.org - October 5, 2012 Category: Cardiology Authors: theheart.org Tags: This week in cardiology from heartwire Source Type: podcasts